Skip to main content
14 December 2024
Last updated:
Monday 9 December 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Strategy
Strategy
European biopharma forecasts for 2024
Read more
Caszyme pioneers gene editing from Lithuania
Read more
Zealand Pharma maps out strategy for obesity
Read more
The weight loss sector continues to evolve
Read more
Unlocking value in pharma R&D
Read more
Raising the threshold: argenx predicts continued market expansion
Read more
Provincialism holds back Europe's biotech sector
Read more
Changes in the landscape for genome editing
Read more
A new therapeutic approach for IgA nephropathy
Read more
Swiss biotech helped by international deals, drug wins, By Jane Morrison
Read more
Pagination
Page 1
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form